ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2019

Genome-Wide CRISPR-Cas9 Screening Identifies NF-κB/E2F6 Responsible for EGFRvIII-Associated Temozolomide Resistance in Glioblastoma.

Kai Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.